291 related articles for article (PubMed ID: 15130779)
1. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage.
Ihara Y; Yoshimura M; Miyoshi E; Nishikawa A; Sultan AS; Toyosawa S; Ohnishi A; Suzuki M; Yamamura K; Ijuhin N; Taniguchi N
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2526-30. PubMed ID: 9482919
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III.
Kang SK; Chung TW; Lee JY; Lee YC; Morton RE; Kim CH
J Biol Chem; 2004 Jul; 279(27):28106-12. PubMed ID: 15123606
[TBL] [Abstract][Full Text] [Related]
5. New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice.
Yang X; Bhaumik M; Bhattacharyya R; Gong S; Rogler CE; Stanley P
Cancer Res; 2000 Jun; 60(12):3313-9. PubMed ID: 10866326
[TBL] [Abstract][Full Text] [Related]
6. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
7. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
Ito Y
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
[TBL] [Abstract][Full Text] [Related]
9. N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N-acetylglucosaminyltransferase III gene.
Okada T; Ihara H; Ito R; Nakano M; Matsumoto K; Yamaguchi Y; Taniguchi N; Ikeda Y
Glycobiology; 2010 Sep; 20(9):1147-59. PubMed ID: 20554946
[TBL] [Abstract][Full Text] [Related]
10. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Yang X; Tang J; Rogler CE; Stanley P
Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
[TBL] [Abstract][Full Text] [Related]
11. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration.
Miyoshi E; Ihara Y; Nishikawa A; Saito H; Uozumi N; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
Hepatology; 1995 Dec; 22(6):1847-55. PubMed ID: 7489997
[TBL] [Abstract][Full Text] [Related]
13. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III.
Rouwendal GJ; Wuhrer M; Florack DE; Koeleman CA; Deelder AM; Bakker H; Stoopen GM; van Die I; Helsper JP; Hokke CH; Bosch D
Glycobiology; 2007 Mar; 17(3):334-44. PubMed ID: 17179169
[TBL] [Abstract][Full Text] [Related]
14. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
[TBL] [Abstract][Full Text] [Related]
15. beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells.
Shigeta M; Shibukawa Y; Ihara H; Miyoshi E; Taniguchi N; Gu J
Glycobiology; 2006 Jun; 16(6):564-71. PubMed ID: 16531477
[TBL] [Abstract][Full Text] [Related]
16. Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization.
Yoshimura M; Ihara Y; Ohnishi A; Ijuhin N; Nishiura T; Kanakura Y; Matsuzawa Y; Taniguchi N
Cancer Res; 1996 Jan; 56(2):412-8. PubMed ID: 8542600
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease.
Akasaka-Manya K; Manya H; Sakurai Y; Wojczyk BS; Kozutsumi Y; Saito Y; Taniguchi N; Murayama S; Spitalnik SL; Endo T
Glycobiology; 2010 Jan; 20(1):99-106. PubMed ID: 19776078
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation.
Ito Y; Akinaga A; Yamanaka K; Nakagawa T; Kondo A; Dickson RB; Lin CY; Miyauchi A; Taniguchi N; Miyoshi E
Glycobiology; 2006 May; 16(5):368-74. PubMed ID: 16464868
[TBL] [Abstract][Full Text] [Related]
19. A glycomic approach to hepatic tumors in N-acetylglucosaminyltransferase III (GnT-III) transgenic mice induced by diethylnitrosamine (DEN): identification of haptoglobin as a target molecule of GnT-III.
Ekuni A; Miyoshi E; Ko JH; Noda K; Kitada T; Ihara S; Endo T; Hino A; Honke K; Taniguchi N
Free Radic Res; 2002 Aug; 36(8):827-33. PubMed ID: 12420740
[TBL] [Abstract][Full Text] [Related]
20. N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice.
Shao DM; Wang QH; Chen C; Shen ZH; Yao M; Zhou XD; Tang ZY; Gu JX
J Exp Clin Cancer Res; 1999 Sep; 18(3):331-5. PubMed ID: 10606178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
